SCP
TECH icon

Sandhill Capital Partners’s Bio-Techne TECH Stock Holding History

Sandhill Capital Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-420,215
Closed -$30.3M – 102
2024
Q4 		$30.3M Sell
420,215
-137,003
-25% -$10.1M 2.37% 21
2024
Q3 		$44.5M Sell
557,218
-12,663
-2% -$952K 3.17% 17
2024
Q2 		$40.8M Sell
569,881
-129,401
-19% -$9.52M 3.13% 17
2024
Q1 		$49.2M Buy
699,282
+8,583
+1% +$614K 3.94% 9
2023
Q4 		$53.3M Buy
690,699
+77,638
+13% +$5.11M 4.43% 5
2023
Q3 		$41.7M Buy
613,061
+110,614
+22% +$8.74M 3.9% 9
2023
Q2 		$41M Buy
502,447
+1,388
+0.3% +$112K 3.74% 10
2023
Q1 		$37.2M Buy
501,059
+32,713
+7% +$2.52M 3.56% 10
2022
Q4 		$38.8M Sell
468,346
-10,338
-2% -$821K 4.14% 6
2022
Q3 		$34M Buy
478,684
+89,156
+23% +$7.7M 3.88% 7
2022
Q2 		$33.8M Sell
389,528
-50,228
-11% -$4.71M 3.61% 8
2022
Q1 		$47.6M Sell
439,756
-46,972
-10% -$4.85M 4.09% 5
2021
Q4 		$63M Buy
486,728
+2,732
+0.6% +$335K 4.89% 1
2021
Q3 		$58.6M Sell
483,996
-24,872
-5% -$3.03M 4.7% 1
2021
Q2 		$57.3M Sell
508,868
-2,272
-0.4% -$239K 4.47% 1
2021
Q1 		$48.8M Sell
511,140
-44,316
-8% -$4.04M 4.14% 3
2020
Q4 		$44.1M Buy
555,456
+828
+0.1% +$60K 4.03% 7
2020
Q3 		$34.3M Sell
554,628
-102,616
-16% -$6.68M 3.46% 8
2020
Q2 		$43.4M Sell
657,244
-44,716
-6% -$2.68M 5.08% 1
2020
Q1 		$33.3M Buy
701,960
+5,772
+0.8% +$289K 4.46% 3
2019
Q4 		$38.2M Buy
696,188
+13,324
+2% +$699K 4.24% 4
2019
Q3 		$33.4M Buy
682,864
+15,904
+2% +$797K 4.07% 4
2019
Q2 		$34.8M Buy
666,960
+21,008
+3% +$1.06M 4.41% 3
2019
Q1 		$32.1M Buy
645,952
+11,208
+2% +$504K 4.48% 3
2018
Q4 		$23M Buy
634,744
+4,516
+0.7% +$189K 3.79% 6
2018
Q3 		$32.2M Buy
630,228
+10,244
+2% +$454K 4.77% 2
2018
Q2 		$22.9M Buy
619,984
+16,200
+3% +$619K 3.63% 7
2018
Q1 		$22.8M Buy
+603,784
New +$21.3M 3.74% 8

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Sandhill Capital Partners's TECH Position: Q1 2025 in Review

Sandhill Capital Partners sold out of Bio-Techne (TECH) in Q1 2025, closing a stake of 420,215 shares — an estimated $30.3M sold.

Sandhill Capital Partners first reported a position in TECH in Q1 2018 and held it in 28 quarters. The position peaked at $63M in Q4 2021. 578 funds tracked by Wall St. Rank hold TECH as of Q1 2025.

  • Sandhill Capital Partners reported no remaining Bio-Techne position as of Q1 2025 after selling out during the quarter.
  • Sandhill Capital Partners sold 420,215 Bio-Techne shares in Q1 2025, an estimated $30.3M.
  • Sandhill Capital Partners first reported a position in Bio-Techne in Q1 2018 and held it in 28 quarters.
  • Sandhill Capital Partners's Bio-Techne position peaked at $63M in Q4 2021.
  • 578 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2025.

Based on Sandhill Capital Partners's 13F filing for Q1 2025, filed 14 May 2025.